Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Pohl

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The European Physical Journal. E, Soft Matter|August 29, 2015
Self-phoretic active particles interacting by diffusiophoresis: A numerical study of the collapsed state and dynamic clusteringOliver Pohl, Holger Stark
Physical Review Letters|June 28, 2014
Dynamic clustering and chemotactic collapse of self-phoretic active particlesOliver Pohl, Holger Stark
Reproductive Sciences (Thousand Oaks, Calif.)|March 8, 2014
Synergistic effects of E2MATE and norethindrone acetate on steroid sulfatase inhibition: a randomized phase I proof-of-principle clinical study in women of reproductive ageOliver Pohl, Elke Bestel, Jean-Pierre Gotteland
Reproductive Sciences (Thousand Oaks, Calif.)|September 18, 2014
The clinical pharmacology and pharmacokinetics of ulipristal acetate for the treatment of uterine fibroidsOliver Pohl, R Howard Zobrist, Jean-Pierre Gotteland
International Journal of Clinical Pharmacology and Therapeutics|November 1, 2012
Changes in gastric pH and in pharmacokinetics of ulipristal acetate - a drug-drug interaction study using the proton pump inhibitor esomeprazoleOliver Pohl, Ian Osterloh, Véronique Lecomte, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|February 27, 2020
Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding-delayed add-back onset does not improve bleeding patternOliver Pohl, Line Marchand, David Bell, et al.
Scientific Reports|November 24, 2016
Active Brownian particles and run-and-tumble particles separate inside a mazeMaryam Khatami, Katrin Wolff, Oliver Pohl, et al.
Therapeutic Innovation & Regulatory Science|February 3, 2020
Efficient Design of Integrated and Adaptively Interlinked Protocols for Early-Phase Drug Development ProgramsSimon Coates, Oliver Pohl, Jean-Pierre Gotteland, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2017
Gonadotropin-Releasing Hormone Receptor Antagonist Mono- and Combination Therapy With Estradiol/Norethindrone Acetate Add-Back: Pharmacodynamics and Safety of OBE2109Oliver Pohl, Line Marchand, Neil Fawkes, et al.
Regulatory Toxicology and Pharmacology : RTP|March 12, 2013
A 39-week oral toxicity study of ulipristal acetate in cynomolgus monkeysOliver Pohl, Alistair R W Williams, Christine Bergeron, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The European Physical Journal. E, Soft Matter|August 29, 2015
Self-phoretic active particles interacting by diffusiophoresis: A numerical study of the collapsed state and dynamic clusteringOliver Pohl, Holger Stark
Physical Review Letters|June 28, 2014
Dynamic clustering and chemotactic collapse of self-phoretic active particlesOliver Pohl, Holger Stark
Reproductive Sciences (Thousand Oaks, Calif.)|March 8, 2014
Synergistic effects of E2MATE and norethindrone acetate on steroid sulfatase inhibition: a randomized phase I proof-of-principle clinical study in women of reproductive ageOliver Pohl, Elke Bestel, Jean-Pierre Gotteland
Reproductive Sciences (Thousand Oaks, Calif.)|September 18, 2014
The clinical pharmacology and pharmacokinetics of ulipristal acetate for the treatment of uterine fibroidsOliver Pohl, R Howard Zobrist, Jean-Pierre Gotteland
International Journal of Clinical Pharmacology and Therapeutics|November 1, 2012
Changes in gastric pH and in pharmacokinetics of ulipristal acetate - a drug-drug interaction study using the proton pump inhibitor esomeprazoleOliver Pohl, Ian Osterloh, Véronique Lecomte, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|February 27, 2020
Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding-delayed add-back onset does not improve bleeding patternOliver Pohl, Line Marchand, David Bell, et al.
Scientific Reports|November 24, 2016
Active Brownian particles and run-and-tumble particles separate inside a mazeMaryam Khatami, Katrin Wolff, Oliver Pohl, et al.
Therapeutic Innovation & Regulatory Science|February 3, 2020
Efficient Design of Integrated and Adaptively Interlinked Protocols for Early-Phase Drug Development ProgramsSimon Coates, Oliver Pohl, Jean-Pierre Gotteland, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2017
Gonadotropin-Releasing Hormone Receptor Antagonist Mono- and Combination Therapy With Estradiol/Norethindrone Acetate Add-Back: Pharmacodynamics and Safety of OBE2109Oliver Pohl, Line Marchand, Neil Fawkes, et al.
Regulatory Toxicology and Pharmacology : RTP|March 12, 2013
A 39-week oral toxicity study of ulipristal acetate in cynomolgus monkeysOliver Pohl, Alistair R W Williams, Christine Bergeron, et al.
Pageof 3